[go: up one dir, main page]

MA64901A1 - Système de distribution de principe actif - Google Patents

Système de distribution de principe actif

Info

Publication number
MA64901A1
MA64901A1 MA64901A MA64901A MA64901A1 MA 64901 A1 MA64901 A1 MA 64901A1 MA 64901 A MA64901 A MA 64901A MA 64901 A MA64901 A MA 64901A MA 64901 A1 MA64901 A1 MA 64901A1
Authority
MA
Morocco
Prior art keywords
active ingredient
distribution system
ingredient distribution
user
delivery system
Prior art date
Application number
MA64901A
Other languages
English (en)
Inventor
Janne JÄRVENPÄÄ
Original Assignee
Opes Corporation Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opes Corporation Oy filed Critical Opes Corporation Oy
Publication of MA64901A1 publication Critical patent/MA64901A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B3/00—Preparing tobacco in the factory
    • A24B3/14—Forming reconstituted tobacco products, e.g. wrapper materials, sheets, imitation leaves, rods, cakes; Forms of such products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un système de distribution de principe actif et son procédé de fabrication. Le système peut comprendre une matrice disposée sur un substrat. La matrice comprend un composant comme principe actif, un support et éventuellement un composant aromatique et éventuellement des composants supplémentaires. Le système d'administration de principe actif peut permettre d'administrer un principe actif à un utilisateur par absorption dans les gencives d'un utilisateur.
MA64901A 2021-09-20 2022-09-20 Système de distribution de principe actif MA64901A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163246089P 2021-09-20 2021-09-20
PCT/FI2022/050629 WO2023041848A1 (fr) 2021-09-20 2022-09-20 Système de distribution de principe actif

Publications (1)

Publication Number Publication Date
MA64901A1 true MA64901A1 (fr) 2024-11-29

Family

ID=83690055

Family Applications (1)

Application Number Title Priority Date Filing Date
MA64901A MA64901A1 (fr) 2021-09-20 2022-09-20 Système de distribution de principe actif

Country Status (22)

Country Link
US (1) US20240269087A1 (fr)
EP (2) EP4404774B1 (fr)
JP (2) JP7710264B2 (fr)
KR (1) KR20240072188A (fr)
CN (1) CN118201503A (fr)
AU (3) AU2022346938B2 (fr)
CA (1) CA3232535A1 (fr)
CL (3) CL2024000812A1 (fr)
DK (1) DK4404774T3 (fr)
ES (1) ES3030034T3 (fr)
FI (1) FI4404774T3 (fr)
HR (1) HRP20250464T1 (fr)
HU (1) HUE071598T2 (fr)
IL (1) IL311530A (fr)
LT (1) LT4404774T (fr)
MA (1) MA64901A1 (fr)
MX (1) MX2024003414A (fr)
PL (1) PL4404774T3 (fr)
PT (1) PT4404774T (fr)
RS (1) RS66724B1 (fr)
SI (1) SI4404774T1 (fr)
WO (1) WO2023041848A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115180A1 (fr) * 2004-05-07 2005-12-08 Cuthof Tobacco Ab Portion de tabac sans fumee
US20070218114A1 (en) * 2004-06-12 2007-09-20 Passionfor Life Healthcare Limited Soluble Strip for Oral or Topical Administration
EP2413919A1 (fr) * 2009-04-02 2012-02-08 Infinite Financial Solutions, Inc. Film de nicotine à dissolution avec ou sans menthol
US9027567B2 (en) * 2008-12-30 2015-05-12 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
CN107874324A (zh) * 2018-01-07 2018-04-06 张宇 一种尼古丁纸质纤维素载体及制作方法
US20190059438A1 (en) * 2009-10-09 2019-02-28 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
EP3192380B1 (fr) * 2016-01-12 2020-11-11 Swedish Match North Europe AB Produit en sachet oral
WO2020259765A1 (fr) * 2019-06-27 2020-12-30 Lts Lohmann Therapie-Systeme Ag Procédé de fabrication de systèmes d'administration de principe actif au moyen d'un procédé d'impression par tampon

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800903A (en) * 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
US6136297A (en) * 1997-06-06 2000-10-24 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
JP2000319167A (ja) * 1999-05-12 2000-11-21 Nitto Denko Corp 口腔内貼付シート
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
EP1617823B1 (fr) * 2003-01-24 2019-01-09 Nicachet AB Sachet contenant une composition de nicotine pour administration par voie transmuqueuse
SE0301244D0 (sv) 2003-04-29 2003-04-29 Swedish Match North Europe Ab Smokeless tobacco product user package
US20050066463A1 (en) 2003-09-25 2005-03-31 Brunner Michael S. Substrates and devices for applying a lip care formulation
US8469036B2 (en) * 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US9044049B2 (en) 2005-04-29 2015-06-02 Philip Morris Usa Inc. Tobacco pouch product
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
DE102008014533A1 (de) * 2008-03-15 2009-09-17 Lts Lohmann Therapie-Systeme Ag Gingival-Wafer
EP2600740A2 (fr) * 2010-08-05 2013-06-12 Altria Client Services Inc. Tissu comprenant du tabac enchevêtré avec des fibres structurelles
WO2013104826A1 (fr) 2012-01-11 2013-07-18 Ka Aroma Marketing Oy Préparation parfumée comprenant un composé parfumé
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
WO2014150967A1 (fr) * 2013-03-15 2014-09-25 Altria Client Services Inc. Produits énergétiques oraux comprenant de la caféine encapsulée
WO2014188079A1 (fr) * 2013-05-23 2014-11-27 Åbo Akademi University Forme posologique imprimée
WO2014198999A1 (fr) 2013-06-13 2014-12-18 Opes Corporation Oy Matrice
US20160192703A1 (en) * 2015-01-07 2016-07-07 R.J. Reynolds Tobacco Company Oral pouch products
MX2017010872A (es) * 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
CN111212576A (zh) * 2017-06-26 2020-05-29 纳德尼古丁公司 烟碱盐及其制备和使用方法
KR101998288B1 (ko) * 2018-03-09 2019-07-09 (주)씨엘팜 무연 담배용 조성물 및 이를 포함하는 구강 용해 필름형 무연 담배
WO2021045753A1 (fr) 2019-09-04 2021-03-11 Vitiprints, LLC Dispositif de distribution d'imprimé ayant des suppléments
RU2745039C1 (ru) * 2019-11-22 2021-03-18 Кирилл Вадимович Альтшуллер Никотинсодержащая съедобная бумага
AU2020400347A1 (en) 2019-12-09 2022-07-07 Nicoventures Trading Limited Layered fleece for pouched product
WO2021165418A1 (fr) * 2020-02-18 2021-08-26 Nerudia Limited Article sans fumée
EP3874970A1 (fr) * 2020-03-03 2021-09-08 Reemtsma Cigarettenfabriken GmbH Matériau de remplissage pour un produit oral sans fumée en sachet et produit oral sans fumée en sachet fabriqué à partir de matériau

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115180A1 (fr) * 2004-05-07 2005-12-08 Cuthof Tobacco Ab Portion de tabac sans fumee
US20070218114A1 (en) * 2004-06-12 2007-09-20 Passionfor Life Healthcare Limited Soluble Strip for Oral or Topical Administration
US9027567B2 (en) * 2008-12-30 2015-05-12 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
EP2413919A1 (fr) * 2009-04-02 2012-02-08 Infinite Financial Solutions, Inc. Film de nicotine à dissolution avec ou sans menthol
US20190059438A1 (en) * 2009-10-09 2019-02-28 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
EP3192380B1 (fr) * 2016-01-12 2020-11-11 Swedish Match North Europe AB Produit en sachet oral
CN107874324A (zh) * 2018-01-07 2018-04-06 张宇 一种尼古丁纸质纤维素载体及制作方法
WO2020259765A1 (fr) * 2019-06-27 2020-12-30 Lts Lohmann Therapie-Systeme Ag Procédé de fabrication de systèmes d'administration de principe actif au moyen d'un procédé d'impression par tampon

Also Published As

Publication number Publication date
DK4404774T3 (da) 2025-04-07
ES3030034T3 (en) 2025-06-26
HRP20250464T1 (hr) 2025-06-06
FI4404774T3 (fi) 2025-05-06
AU2022346938B2 (en) 2025-05-29
JP7710264B2 (ja) 2025-07-18
MX2024003414A (es) 2024-05-10
CL2024000812A1 (es) 2024-11-22
AU2022346938A1 (en) 2024-04-11
CL2025001049A1 (es) 2025-08-08
EP4404774B1 (fr) 2025-02-12
EP4537678A1 (fr) 2025-04-16
HUE071598T2 (hu) 2025-09-28
RS66724B1 (sr) 2025-05-30
AU2025213645A1 (en) 2025-08-28
IL311530A (en) 2024-05-01
SI4404774T1 (sl) 2025-06-30
AU2025213655A1 (en) 2025-08-28
PT4404774T (pt) 2025-04-14
EP4404774A1 (fr) 2024-07-31
CA3232535A1 (fr) 2023-03-23
PL4404774T3 (pl) 2025-06-16
KR20240072188A (ko) 2024-05-23
JP2024535059A (ja) 2024-09-26
JP2025122079A (ja) 2025-08-20
WO2023041848A1 (fr) 2023-03-23
CN118201503A (zh) 2024-06-14
CL2025001048A1 (es) 2025-08-08
LT4404774T (lt) 2025-05-12
US20240269087A1 (en) 2024-08-15

Similar Documents

Publication Publication Date Title
Wood et al. The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol
TNSN08152A1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation
NO953278L (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
AU2019257489A1 (en) Rapid establishment and/or termination of substantial steady-state drug delivery
EA200500084A1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента
MA30814B1 (fr) Nouvelles compositions en depot injectables et leur procede de fabrication
EA201200508A1 (ru) Составы, содержащие фунгицидный штамм и активное соединение
IL188789A0 (en) Formulation and method for administration of ophthalmologically active agents
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
EP2055314A4 (fr) Activateur comprenant un bio-tensioactif comme ingrédient actif, un mannosyl érythritol lipide et son procédé de préparation
EP1429602A4 (fr) Methodes de traitement de troubles au moyen d'extraits des plantes
EP3907186A4 (fr) Procédé de préparation de précurseur de matériau actif d'électrode positive, et précurseur de matériau actif d'électrode positive associé
MA64901A1 (fr) Système de distribution de principe actif
WO2004006854A3 (fr) Procede d'identification d'agents biologiquement actifs
ATE475484T1 (de) Dosiervorrichtung
Kaur et al. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat
ATE434431T1 (de) Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
EP1745786B1 (fr) Composés neuroprotecteurs et compositions pharmaceutiques les comprenant
DK0546389T3 (da) Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet
TW200500093A (en) A platform for transdermal formulations (PTF)
WO2018220444A3 (fr) Compositions et procédés de traitement du syndrome de la kératoconjonctivite sèche par administration d'un antibiotique macrolide
Makhay et al. Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol
FR3107203B1 (fr) Matrice solide composite pour la délivrance prolongée d’actifs
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
RU2004105876A (ru) Способ лечения и профилактики глазных болезней, связанных с нарушением микроциркуляции и/или воспалительными процессами